Introduction
Aortic stiffness as determined using carotid-femoral pulse wave velocity (C-F PWV) is a blood pressureindependent cardiovascular risk factor. 1 C-F PWV of X12 m s -1 has been defined as subclinical target organ damage based on its predictive value for cardiovascular events in patients with end-stage renal disease. 2 Similarly, albuminuria is a risk factor for cardiovascular disease and is closely associated with cardiovascular damage in the general population. 3 Moreover, it reflects kidney damage and the development of renal failure in progressive renal disease without known previous renal damage and in patients with type II diabetes. 4, 5 An association between albuminuria and aortic stiffness was shown in general, hypertensive and diabetic populations. [6] [7] [8] [9] Although chronic kidney disease (CKD) is characterized by increased cardiovascular risk, no data are available with respect to the relationship between aortic stiffness and proteinuria in CKD patients. Moreover, CKD patients often develop proteinuria as the first characteristic of renal disease. 4 In hypertension and diabetes, proteinuria reflects a late phenomenon of cardiovascular target organs, including disease states of ischaemic heart disease, stroke, congestive heart failure and intermittent claudication. 10, 11 The heterogeneous appearance of proteinuria in cohorts with CKD allows a deeper analysis of the direction of dependencies between proteinuria and aortic stiffness in CKD patients when compared with conventional hypertensive or diabetic cohorts.
In this study, we analysed in patients with severeto-mild CKD whether aortic stiffness and proteinuria consistently predict each other, particularly in CKD patients of young age and with predominant or sole renal disease.
Materials and methods

CKD patients
In a cross-sectional setting, 144 patients (65 females and 79 males) with CKD stages 2-5 were analysed for vascular stiffness. Patients were recruited from nephrological outpatients clinic of the Klinikum rechts der Isar from August 2007 to December 2007. The protocol was approved by the local ethics committee, and all patients gave written informed consent.
Except for 12 subjects, all patients were white Caucasians. The original renal diseases were in 20.1% of the patients hypertensive nephropathy, in 28.5% diabetic nephropathy, in 18.8% glomerulonephritis, in 11.8% autoimmune disease, in 4.9% urological disease and in 9.7% chronic interstitial nephritis or polycystic kidney disease. In 6.2% of the patients, the underlying disease was unknown. In 52 patients, diagnosis was biopsyproven.
Blood samples and morning spot urine were collected for biological measurements according to the recommendations of the American and European clinical practice guidelines-K-DOQI (http:// www.kidney.org/professionals/kdoqi/guidelines.cfm). In 12 patients, no urine samples were available. Of these patients, 3 were stage 2, 1 was stage 3, 3 were stage 4 and 5 were stage 5 cases. Hypertension was defined as systolic blood pressure X130 mm Hg and/or diastolic blood pressure X80 mm Hg or the use of antihypertensive drugs. Each subject's blood pressure was the average of three consecutive readings measured at the clinic after X5 min of sitting rest. An automated oscillometric device (Omron, Tokyo, Japan) recorded blood pressure at the upper arm. As for the conventional auscultatory measurements, cuff size was adjusted to the circumference of the upper arm. Standard cuffs had an inflatable bladder of 12 Â 24 cm. Diabetes was defined as fasting blood glucose X6.4 mmol l -1 or the use of anti-diabetic drugs. Dyslipidaemia was defined as hypercholesterolaemia, hypertriglyceridaemia, combined hyperlipidaemia and low levels of highdensity lipoprotein cholesterol. 10 Blood glucose, lipid profile and parathyroid hormone have been determined using routine clinical chemistry. 
Age Â 1.018 (if female) Â 1.159 (if black), in which Scr is serum creatinine, k is 0.7 for females and 0.9 for males, a is À0.329 for females and À0.411 for males, min indicates the minimum of Scr/k or 1, and max indicates the maximum of Scr/k or 1). Both measures correlated strongly (r ¼ 0.997; Po0.001). In the following, data of CKD-EPI are given.
Protein-creatinine ratios were calculated from morning spot urine. Protein-creatinine ratios deviated from normal distribution and were log-transformed. Proteninuria was defined as protein-creatinine ratio X200 mg of protein per g of creatinine. Information about cardiovascular factors was obtained from medical records.
Pulse wave velocity C-F PWV was assessed using sensitive transducers and the results were analysed using the Complior program (Complior, Artech Medical, Pantin, France). First, patients rested in the supine position for 5 min. Brachial blood pressure was measured using oscillometric device (Omron). Pressure-sensitive sensors were placed on the right carotid and femoral artery. 13 The distance between the two sites (carotid-femoral) was estimated automatically according to the body height of the patients. The time difference was determined from the delay of starting phase of the first wave between the carotid and another site ('foot-to-foot method'). C-F PWV was calculated by dividing the distance by the time difference. At least 10 signals were obtained twice and averaged to the results. In the case of an intrapatient variance of 410%, a third measurement was performed. Data were collected by a single observer (PCR). The intra-observer coefficient of variation for C-F PWV was 2.5%.
Statistical analysis
Statistics were performed using SPSS software version 15.0 (SPSS Inc., Chicago, IL, USA). Variables with skewed distributions were logarithmically transformed. Comparisons of means and proportions between genders were performed using Student's t-test and chi-square test, respectively. The difference between C-F PWV and different eGFR categories was analysed using analysis of variance. Univariate and adjusted correlations were used to analyse the relationships between variables. Multivariate regressions with stepwise selection of variables were performed to analyse the independent relationships, with entry P ¼ 0.10 and removal P ¼ 0.15. Logistics regression was used to observe the risk factors for proteinuria.
To sort out the redundant variables for multivariate regression analysis, we used classifications defined by Briet et al.
14 as a reference and constituted clusters corresponding to pathophysiological characteristics, which are as follows: morphometric (sex, height, weight, body mass index (kg m -2 )), blood pressure (mean arterial pressure and pulse pressure), lipids (total cholesterol, high-density lipoprotein, low-density lipoprotein and triglycerides), blood (haematocrit, haemoglobin and white blood cells), mineral metabolism (calcium, phosphorus and intact parathyroid hormone) and treatment (angiotensin-converting enzyme inhibitor (ACEI), diuretics, angiotensin II type 1 receptor blockers, b-receptor blockers and calcium channel blockers). In each cluster, the variable that had the highest level of covariance with dependent factor (for example, C-F PWV and eGFR) in the standardization condition was retained and included in the regression model. Age as an independent variable entered the model.
Results
The anthropometric and clinical characteristics of the studied population are given in Table 1 . Female and male participants were comparable in age, body mass index, lipids, serum creatinine, eGFR, proteincreatinine ratio, supine diastolic blood pressure, pulse pressure and heart rate. No gender difference was present for C-F PWV. The prevalence rates of hypertension, diabetes, dyslipidaemia and proteinuria were similar in both genders. Median proteincreatinine ratios (original) for female and male subjects were 136.0 (25th percentile: 99.0, 75th percentile: 500.0) and 200.0 (25th percentile: 92.8, 75th percentile: 756.2), respectively. Compared with women, men had increased supine systolic blood pressure and mean arterial pressure. Men were more often treated with angiotensin converting enzyme inhibitors (angiotensin-converting enzyme inhibitor; Po0.001).
eGFR and arterial stiffness index Age, protein-creatinine ratio, pulse pressure and C-F PWV related negatively with eGFR, whereas diastolic blood pressure related positively with eGFR (Po0.05). When adjusted for age, sex, systolic blood pressure, pulse pressure and heart rate, the significant relationship between eGFR and C-F PWV disappeared (P ¼ 0.45). In the multivariate regression analysis, intact parathyroid hormone, proteincreatinine ratio and age were the independent predictors for eGFR and explained in total 39.1% of variance and 8.1% by protein-creatinine ratio alone (Table 2 ). C-F PWV could not be included in the model. On the contrary, eGFR was not a determinant for C-F PWV (Table 2) .
When considering whether C-F PWV varied depending on the different grades of CKD, we divided subjects into four categories according to their eGFR (o15; 15-29; 30-59; and X60 ml min -1 1.73 m -2 ). Then, the relationships between C-F PWV and eGFR categories were analysed (Figure 1 ). The C-F PWV of the highest eGFR category (eGFR 460 ml min ) was nonsignificantly reduced when compared with the other eGFR categories (P ¼ 0.06). However, in the regression analysis, neither individual eGFR values nor eGFR categories predicted C-F PWV (data not shown).
Protein-creatinine ratio and arterial stiffness
In the multivariate analysis of the protein-creatinine ratio, the factors such as eGFR, body mass index, age and C-F PWV were independent predictors, with eGFR explaining 4.0% and C-F PWV 2.6% of the variance (Table 2) . Mean arterial pressure was excluded from the equation. A significant independent relationship between protein-creatinine ratio and C-F PWV was confirmed (partial r ¼ 0.17).
Protein-creatinine ratio was negatively related to age, body mass index and eGFR. Age, heart rate, sex, protein-creatinine ratio and mean arterial pressure were independently related with C-F PWV, with the protein-creatinine ratio explaining 1.6% of the variance and the total explaining 46.1% (Table 2) .
To find the relationship between proteinuria and C-F PWV, proteinuria was put as a dummy variable (0 ¼ no proteinuria and 1 ¼ proteinuria) in the regression analysis for C-F PWV. The state of proteinuria predicted the raise of C-F PWV, accounting for 1.4% of variance (data not shown).
Age was classified into five categories (o40; 40-50; 51-60; 61-70; and 470 years). C-F PWV was divided into three categories (o10; 10-12; and 412 m s -1 ). Risk factors for proteinuria were analysed using the odds ratio. Mean arterial pressure and intact parathyroid hormone were strong predictors for the incidence of proteinuria (Table 3) . C-F PWV, age and eGFR did not predict proteinuria. Figure 2 depicts the prevalence of proteinuria in relation to the age categories for the linear trend of C-F PWV. On the basis of low C-F PWV in patients aged p50 years, despite the high prevalence of proteinuria, the original disease was analysed in these subjects. In all, 37 patients were o50 years, of whom 23 had glomerulonephritis as underlying disease, whereas 14 patients had other diseases resulting in impaired renal function such as renal artery stenosis, eclampsia, diabetic nephropathy, hypertensive nephropathy and interstitial nephritis. Between these groups, blood pressure and aortic stiffness differed significantly, whereas age, eGFR and proteinuria were comparable (Table 4) .
Discussion
In this cross-sectional cohort of CKD, patient's aortic stiffness predicted the degree of urinary proteincreatinine ratio and vice versa. However, C-F PWV lost its predictive value after stratification for apparent or non-apparent clinical proteinuria defined as X200 mg of protein per g of creatinine in spot urine. Proteinuria is a strong predictor of cardiovascular disease in the general population 9 and in patients with CKD. 4 Evidence has accumulated that aortic PWV in patients with end-stage renal disease is elevated and predicts future cardiovascular events. 2, 15, 16 The blood pressure-independent predictive value of PWV has been confirmed in the general population as well as in hypertensive and diabetic individuals. 1, [17] [18] [19] Furthermore, several studies have suggested a relationship between albuminuria and aortic stiffness, with age as a major determinant for the increase in both factors. [6] [7] [8] 20 CKD is widely associated with proteinuria. 4 In this context, we describe that proteinuria and aortic PWV are independent predictors for each other. 
Abbreviations: BMI, body mass index; C-F PWV, carotid--femoral pulse wave velocity; CKD-EPI, chronic kidney disease-Epidemiology Collaboration; eGFR, estimated glomerular filtration rate; iPTH, intact parathyroid hormone; MAP, mean arterial pressure. Aortic stiffness and proteinuria in CKD CR Pan et al Therefore, we confirm previous observations regarding proteinuria and stiffness in diabetic and hypertensive patients. 7, 20 In addition, this finding complements the observation that brachial-ankle PWV is elevated in CKD patients with proteinuria measured using the semiquantitative dip-stick method 21 and the finding that proteinuria above 1 g per day yields in higher aortic PWV. 22 Our findings may partially depend on the blood pressure effect on stiffness and intraglomerular pressure, which is associated with proteinuria. 23 Second, the global abnormality of endothelial function is mirrored by proteinuria and atherosclerotic changes resulting in increased stiffness. 24, 25 Third, vascular remodelling, a major pathophysiological keystone of stiffness, is related to proteinuria. 26 Taken together, it is likely that proteinuria and stiffness depend on each other on the basis of the time-related aggravation of the basic pathomechanisms. 7 However, the acute onset of a kidney disease is not necessarily associated with a long history of the abovementioned factors, but with reno-specific alterations such as glomerulonephritis. 27 Their acute onset and partially sole renal localization renders a relationship on the abovementioned factors unlikely. Therefore, we performed a dichotomous analysis for apparent proteinuria (X200 mg of protein per g of creatinine). Indeed, aortic stiffness did not predict the state of clinical apparent proteinuria. Second, we showed that particular younger subjects with glomerulonephritis had lower aortic stiffness. Under these circumstances, aortic stiffness and proteinuria are not associated with each other.
Finally, our study confirms earlier results that GFR o60 ml min -1 using the renal clearance of 51 Cr-EDTA is not significantly related to stiffness. 14 However, our cohort additionally includes more patients with mild CKD (stage 2) than does the study of Briet et al.
14 In addition, the very early forms, in particular, tend to present reduced aortic stiffness as suggested by Mourad et al. 28 Whether eGFR is related to aortic stiffness as based on CKD stages and whether a clinical relevant cutoff point can be defined have to be further analysed.
In conclusion, our results show that the degree of proteinuria and aortic stiffness depend on each other in CKD patients as in other cohorts of the cardiovascular continuum. However, choosing apparent proteinuria (X200 mg of protein per g of creatinine) as variable for CKD patients, the predictive value is restricted to aortic stiffness, whereas stiffness does not predict apparent proteinuria in these patients. This finding may be related to the early onset of disease-related proteinuria in young CKD patients, which contrasts with the age-related aggravation of stiffness.
What is known about the topic K Aortic stiffness, as determined using carotid-femoral pulse wave velocity (C-F PWV), is a blood pressure-independent cardiovascular risk factor. 1 C-F PWV X12 m s -1 has been defined as subclinical target organ damage based on its predictive value for cardiovascular events in patients with end-stage renal disease. 2 K Albuminuria is closely associated with cardiovascular damage 3 and reflects kidney damage. 4, 5 An association between albuminuria and aortic stiffness was shown in general, hypertensive and diabetic populations. [6] [7] [8] [9] What this study adds K The degree of proteinuria and aortic stiffness depend on each other in CKD patients as in other cohorts of the cardiovascular continuum. However, choosing apparent proteinuria (X200 mg of protein per g of creatinine) as variable for CKD patients the predictive value is restricted to aortic stiffness, whereas stiffness does not predict apparent proteinuria in these patients. This finding may be related to the early onset of disease-related proteinuria in young CKD patients, which contrasts the age-related aggravation of stiffness.
